Carla Nawrocki - Auxly Cannabis Senior Strategy
| XLY Stock | CAD 0.08 0.01 5.88% |
Executive
Carla Nawrocki is Senior Strategy of Auxly Cannabis Group
| Address | 777 Richmond Street West, Toronto, ON, Canada, M6J 0C2 |
| Phone | (647) 812-0121 |
| Web | https://www.auxly.com |
Auxly Cannabis Management Efficiency
As of the 21st of March 2025, Return On Tangible Assets is likely to grow to -0.21. In addition to that, Return On Capital Employed is likely to grow to -0.13. At this time, Auxly Cannabis' Total Assets are very stable compared to the past year. As of the 21st of March 2025, Non Current Assets Total is likely to grow to about 236.6 M, while Other Current Assets are likely to drop about 3 M. Auxly Cannabis' management efficiency ratios could be used to measure how well Auxly Cannabis manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Brett Moon | Medipharm Labs Corp | N/A | |
| Geoffrey Marr | Medipharm Labs Corp | N/A | |
| Randy Daigneau | Tilray Inc | N/A | |
| Nathalie Kubrick | OrganiGram Holdings | N/A | |
| Mitchell JD | Tilray Inc | 59 | |
| Saravan Subramaniam | Medipharm Labs Corp | N/A | |
| Borna Zlamalik | OrganiGram Holdings | N/A | |
| Berrin Noorata | Tilray Inc | N/A | |
| Geoffrey Riggs | OrganiGram Holdings | N/A | |
| Mitchell Gendel | Tilray Inc | 58 | |
| Nyree Pinto | Tilray Inc | N/A | |
| Roger Savell | Tilray Inc | 63 | |
| John Sadler | Tilray Inc | N/A | |
| Kirk Binns | Medipharm Labs Corp | N/A | |
| Nathalie Batten | OrganiGram Holdings | N/A | |
| Katrina McFadden | OrganiGram Holdings | N/A | |
| Megan McCrae | OrganiGram Holdings | N/A | |
Management Performance
| Return On Equity | -0.71 | ||||
| Return On Asset | -3.0E-4 |
Auxly Cannabis Group Leadership Team
Elected by the shareholders, the Auxly Cannabis' board of directors comprises two types of representatives: Auxly Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Auxly. The board's role is to monitor Auxly Cannabis' management team and ensure that shareholders' interests are well served. Auxly Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Auxly Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ian Rapsey, Chief Officer | ||
| Ron Fichter, General Secretary | ||
| Hugo Alves, CEO Director | ||
| Vladimir Klacar, Senior Planning | ||
| Alan Cooke, VP Operations | ||
| Brian Schmitt, Chief Officer | ||
| Kevin Furet, Chief Officer | ||
| Michael Lickver, President | ||
| Andrew MacMillan, Senior Commercial | ||
| Carla Nawrocki, Senior Strategy | ||
| Travis Wong, Chief Officer |
Auxly Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Auxly Cannabis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | ||||
| Return On Asset | -3.0E-4 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 159.06 M | ||||
| Shares Outstanding | 1.28 B | ||||
| Shares Owned By Insiders | 21.23 % | ||||
| Shares Owned By Institutions | 0.16 % | ||||
| Number Of Shares Shorted | 736.52 K | ||||
| Price To Book | 0.96 X |
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.